HEALTH● ELEVATEDJul 30 · Jul 30, 2026, 10:00 AM
First-of-kind Guillain-Barré drug switches off part of immune system
New Scientist
A treatment that turns off the bit of the immune system that goes haywire in Guillain-Barré syndrome may be the first targeted therapy approved for the autoimmune condition
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH30m agoEbola: NCDC urges hospitals to act before laboratory confirmationPremium TimesHEALTH51m agoFree medical camp held for construction workers in VelloreThe HinduHEALTH55m agoEbola: NCDC warns misinformation could undermine Nigeria’s responsePremium TimesHEALTH59m agoEbola: NCDC approves ₦100,000 weekly allowance for quarantined contactsPremium Times